EP1137737A1 - Liquid crystal compound - Google Patents

Liquid crystal compound

Info

Publication number
EP1137737A1
EP1137737A1 EP99954281A EP99954281A EP1137737A1 EP 1137737 A1 EP1137737 A1 EP 1137737A1 EP 99954281 A EP99954281 A EP 99954281A EP 99954281 A EP99954281 A EP 99954281A EP 1137737 A1 EP1137737 A1 EP 1137737A1
Authority
EP
European Patent Office
Prior art keywords
coo
chiral
formula
group
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99954281A
Other languages
German (de)
French (fr)
Inventor
Angela Ohlemacher
Jürg FÜNFSCHILLING
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rolic Technologies Ltd
Original Assignee
Rolic AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rolic AG filed Critical Rolic AG
Publication of EP1137737A1 publication Critical patent/EP1137737A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/3444Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing one nitrogen atom, e.g. pyridine
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/345Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing two nitrogen atoms
    • C09K19/3458Uncondensed pyrimidines
    • C09K19/3466Pyrimidine with at least another heterocycle in the chain
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K2019/3422Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a six-membered ring

Definitions

  • the present invention relates to liquid crystal compounds, particularly ferroelectric liquid crystal compounds or compounds for use in the preparation of liquid crystal mixtures having ferroelectric properties.
  • ferroelectric liquid crystal phases in the preparation of ferroelectric liquid crystal devices is known. See, for example, Clark and Largerwall, Appl. Phys. Lett. 1980, 36, 899.
  • Ferroelectric liquid crystal devices FLCDs have been found to overcome the limitations associated with devices based on nematic liquid crystal (LC) compounds and mixtures. These limitations include a limited range of viewing angles and relatively slow switching times.
  • Ferroelectric liquid crystal (FLC) phases comprise chiral smectic liquid crystal compounds.
  • the LC molecules are arranged in layers.
  • the director can be either orthogonal to the layer (e.g. smectic-A or S ⁇ ) or tilted (smectic-C or Sc).
  • smectic-C or Sc tilted
  • at least one component comprising the liquid crystal phase has to be chiral.
  • the chiral Sc-phase is denoted by Sc*.
  • a FLC-mixture usually comprises one or more non-chiral components and one or more chiral dopants.
  • the non-chiral component is generally not required for the preparation of FLCs.
  • pyrimidinyl compounds in liquid crystal applications are well known.
  • US 4,774,020 discloses liquid crystal materials, which include a pyrimidinyldioxane derivative. These compounds have been used in nematic liquid crystal applications. Examples of known pyrimidinyl compounds that have found application in ferroelectric liquid crystal applications can be found in WO 96/30344. These include halogen substituted pyrimidinyldioxane derivatives.
  • a first aspect of the invention provides a compound of formula (I)
  • R 1 represents a chiral or non-chiral, branched or straight chain C ⁇ -2 ⁇ alkyl or
  • a and B are each independently a 1.4-phenylene or 1 ,4-cyclohexylene group, which may each be optionally substituted by halogen, cyano or nitro or a group of formula R 1 and in which one or two non-adjacent -CH- or -CH 2 - groups may be optionally replaced by nitrogen or oxygen respectively;
  • n are each independently 0 or 1 ;
  • MG represents a 1,4 phenylene group which may be optionally substituted by hhaallooggeenn,, ccyyaannoo oorr nniittrroo oorr aa ggrroouupp ooff ffoorrmmuullaa RR 11 and in which one or two non-adjacent -CH- groups is replaced by nitrogen.
  • the dioxane-pyridine and -pyrimidine derivatives of the present invention may be included in ferroelectric LC mixtures. This allows a skilled person to selectively optimize certain mixture parameters.
  • the parameters that can be optimized include:
  • a large tilt angle This is important in applications such as DHF-LCDs because it facilitates the preparation of devices having a high brightness.
  • the suppression of the S A -phase This is important in applications such as APD-LCDs which require an N-Sc* transition without an intervening S ⁇ -phase.
  • a low birefringence ⁇ n The dioxane-phenyl-pyrimidine compounds of the present invention have lower birefringence than other common wide temperature range
  • the group R 1 is preferably a branched or straight chain C 5- i 6 alkyl group.
  • the group R ⁇ is preferably a branched or straight chain alkoxy or C 5- i 6 alk- enyloxy group.
  • the groups R and R may, independently of each other, be chiral.
  • the group MG 1 is preferably a 1 ,4-phenylene group, which is optionally substituted by halogen, cyano, nitro, an alkyl or alkoxy group.
  • Z 1 , Z 2 and Z 3 are each preferably a single bond.
  • alkyl should be understood to include groups such as methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl and dodecyl.
  • alkenyl should be understood to include groups such as E or Z alkenyl as well as alkenyl groups with a terminal double bond.
  • Examples of such groups include allyl, 2-butenyl, 2-pentenyl, 2-hexenyl, 2-heptenyl, 2-octenyl, 2-nonenyl, 2-decenyl, 3-but- enyl, 3-pentenyl, 3-hexenyl, 3-heptenyl, 3-octenyl, 3-nonenyl, 3-decenyl, 4-pentenyl, 4-hexenyl, 4-heptenyl, 4-octenyl, 4-nonenyl, 4-decenyl, 5-hexenyl, 6-heptenyl, 7-octenyl, 8-nonenyl, 9-decenyl, 10-undecyl, 1 1-dodecenyl and the like.
  • alkoxy should be understood to include groups such as methoxy, ethoxy, n-propoxy, isopropoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy, decyloxy, undecyloxy and dodecyloxy.
  • alkenyloxy should be understood to include groups such as 2E-alk- enyloxy, 3Z-alkenyloxy, 4E-alkenyloxy and alkenyloxys with a terminal double bond.
  • the terms "2E-alkenyloxy”, “3Z-alkenyloxy” and “4E-alkenyloxy” embrace straight chain alkenyloxy groups with 3 or more, 4 or more and 5 or more carbon atoms respectively in which the double bond is present in the 2. 3 and 4 positions respectively, with E and Z denoting the configuration of the double bond.
  • Such groups include 2E-butenyloxy.
  • alkylcarbonyloxy should be understood to include groups such as methylcarbonyloxy, ethylcarbonyloxy, propylcarbonyloxy, butylcarbonyloxy. pentylcarbonyloxy, hexylcarbonyloxy, octylcarbonyloxy. nonylcarbonyloxy. decylcarbonyloxy, undecylcarbonyloxy and dodecylcarbonyloxy.
  • alkenylcarbonyloxy should be understood to include groups such as lE-alkenylcarbonyloxy, 2Z-alkenylcarbonyloxy, 3E-alkenylcarbonyloxy, 4Z-alkenyl- carbonyloxy and alkenylcarbonyloxys with a terminal double bond.
  • alkenylcarbonyloxy should be understood to include groups such as lE-alkenylcarbonyloxy, 2Z-alkenylcarbonyloxy, 3E-alkenylcarbonyloxy, 4Z-alkenyl- carbonyloxy and alkenylcarbonyloxys with a terminal double bond.
  • alkenylcarbonyloxy should be understood to include groups such as lE-alkenylcarbonyloxy, 2Z-alkenylcarbonyloxy, 3E-alkenylcarbonyloxy, 4Z-alkenyl- carbonyloxy and alkenylcarbonyloxys with a terminal double bond.
  • "3E-alkenylcarbonyloxy” and “4Z-alk- enylcarbonyloxy” embrace straight chain alkenyl groups with 3 or more, 4 or more and 5 or more carbon atoms respectively in which the double bond is present in the 2, 3 and 4 positions respectively, with E and Z denoting the configuration of the double bond.
  • Such groups include allylcarbonyloxy, 2Z-butenylcarbonyloxy, 2Z-pentenylcarbonyloxy. 2Z-hexenylcarbonyloxy, 2Z-heptenylcarbonyloxy, 2Z-octenylcarbonyloxy, 2Z-nonenyl- carbonyloxy, 2Z-decenylcarbonyloxy. 3-butenylcarbonyloxy, 3E-pentenylcarbonyloxy.
  • halogen is understood to include groups such as fluorine, chlorine, bromine and iodine.
  • R , R " and Z are as defined above for the compound of formula (I);
  • X represents -CH- or nitrogen.
  • each of L 1 to L 5 represents hydrogen.
  • a second aspect of the invention provides a method for the preparation of the compounds of the invention which comprises the steps of reacting an ether of 4-(5-hydroxy-2-pyrimidyl)benzaldehyde with a 2-alkylpropane-
  • EDC is N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride
  • DMAP is 4-dimethylaminopyridine
  • DCM is dichloromethane
  • POCl 3 is phosphorous oxychloride Et 3 N is triethylamine
  • DIBAH is diisobutylaluminum hydride
  • the compounds of the invention may be used alone or as a component of a ferroelectric liquid crystal mixture.
  • a third aspect of the invention therefore provides a ferroelectric liquid crystal mixture comprising a compound of formula (I), the liquid crystal mixture comprising at least two components.
  • the additional component or components of the liquid crystal mixture may comprise one or more compounds of formula (I) or, alternatively, may include other suitable known mesogenic or non-mesogenic compounds.
  • the additional liquid crystal components must be miscible with the compounds of formula (I). Examples of known mesogenic materials suitable for use with the compounds of the present invention are listed below. Further examples of additional components that may be used in the mixtures of the present invention can be found in US 4,898,455. US 4,929,278, US 5.082,589, US 5.238,602, US 5,100.577 and US 5,242,619.
  • Ferroelectric liquid crystal mixtures may be readily prepared by admixing the compounds of formula (I) with one or more additional mesogenic or non-mesogenic components.
  • a fourth aspect of the invention therefore provides a method of preparing a ferroelectric liquid crystal mixture comprising admixing a compound of formula (I) with a further mesogenic or non-mesogenic compound.
  • the one or more additional components may include further compounds of formula (I) or other suitable mesogenic or non-mesogenic components such as those referred to above.
  • the compounds of the invention may be used in the preparation of ferroelectric liquid crystal devices. As indicated above, such devices have been found to exhibit superior optical and electro-optical properties.
  • a fifth aspect of the invention therefore provides the use of a compound of formula (I) in the preparation of a ferroelectric liquid crystal device.
  • the compounds of formula (I) may be used alone but are most preferably used in the form of a liquid crystal mixture as defined above.
  • the invention also includes an optic or electo-optic device comprising a compound of formula (I) in addition to an optic or electro-optic device comprising a liquid crystal mixture as defined above.
  • an optic or electo-optic device comprising a compound of formula (I) in addition to an optic or electro-optic device comprising a liquid crystal mixture as defined above.
  • a ferroelectric liquid crystal mixture, SCO-1014 having the composition shown in table
  • Table I The composition of the test mixture SCO-1014.
  • N, S A and Sc* are the upper temperature limits of the corresponding LC-phases.
  • a missing phase is denoted by "-".
  • 2 ⁇ is the observed switching angle at 25°C, measured in test cells with 1 OV pp / ⁇ m square wave field applied.
  • test cells have ITO electrodes, low-tilt, parallel-brushed polyimide orientation layers and a cell gap of 1 O ⁇ m.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Liquid Crystal Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal (AREA)

Abstract

A compound of formula (I), in which R1 represents a chiral or non-chiral, branched or straight chain C¿1-20? alkyl or C1-20 alkenyl, which may be optionally substituted by one or more halogen atoms and in which one or more non-adjacent -CH2- groups may be optionally replaced by -CH=CH-, -O-, -CO-, -COO-, -OOC-, -O-OC-O- or -S-; R?2¿ represents a chiral or non-chiral, branched or straight chain C¿1-20? alkoxy, C1-20 alkenyloxy, C1-20 alkylcarbonyloxy (alkyl-COO-) or C1-20 alkenyl carbonyloxy (alkenyl-COO-), which may be optionally substituted by one or more halogen atoms and in which one or more non-adjacent -CH2- groups may be optionally replaced by -CH=CH-, -O-, -CO-, -COO-, -OOC-, -O-OC-O- or -S-;MG?1¿ represents a group of formula (Ia):-(A-Z2)n-(B-Z3)m, in which A and B are each independently a 1,4-phenylene or 1,4-cyclohexylene group, which may each be optionally substituted by halogen, cyano or nitro or a group of formula R1 and in which one or two non-adjacent -CH- or -CH¿2?- groups may be optionally replaced by nitrogen or oxygen respectively; Z?1, Z2, Z3¿ independently represent a single bond, -COO- or -OOC-, -CH¿2?CH2-, -CH=CH-, -C C-, -OCH2- or -CH2O-;m and n are each independently 0 or 1; and MG?2¿ represents a 1,4 phenylene group which may be optionally substituted by halogen, cyano or nitro or a group of formula R1 and in which one or two non-adjacent -CH- groups is replaced by nitrogen is provided. The compound is useful in the preparation of ferroelectric liquid crystal devices.

Description

Liquid Crystal Compound The present invention relates to liquid crystal compounds, particularly ferroelectric liquid crystal compounds or compounds for use in the preparation of liquid crystal mixtures having ferroelectric properties. The use of ferroelectric liquid crystal phases in the preparation of ferroelectric liquid crystal devices is known. See, for example, Clark and Largerwall, Appl. Phys. Lett. 1980, 36, 899. Ferroelectric liquid crystal devices (FLCDs) have been found to overcome the limitations associated with devices based on nematic liquid crystal (LC) compounds and mixtures. These limitations include a limited range of viewing angles and relatively slow switching times.
Ferroelectric liquid crystal (FLC) phases comprise chiral smectic liquid crystal compounds. In smectic phases, the LC molecules are arranged in layers. The director can be either orthogonal to the layer (e.g. smectic-A or SΛ) or tilted (smectic-C or Sc). For ferroelectricity to occur, at least one component comprising the liquid crystal phase has to be chiral. The chiral Sc-phase is denoted by Sc*. A FLC-mixture usually comprises one or more non-chiral components and one or more chiral dopants. The non-chiral component is generally not required for the preparation of FLCs. However, the preparation of FLC mixtures containing a non-chiral component means that there is a large design flexibility available in respect to the manufacture of LCDs. The spontaneous polarization associated with ferroelectric liquid crystal phases and the strong interaction of such liquid crystal phases with applied electric fields means that these materials are able to provide a very fast electro-optic response, Meyer et al. J. Physique Lett. 1975, 36, L-69- L-71. In addition, in contrast to nematic LCs, ferroelectric liquid crystals are able to exhibit a linear electro-optic response in the field. This means that ferroelectrics can be switched on and off with equal speed by reversing the sign of the applied voltage: in contrast to nematic LCDs, both transitions are driven by the electric field.
The use of pyrimidinyl compounds in liquid crystal applications is well known. US 4,774,020 discloses liquid crystal materials, which include a pyrimidinyldioxane derivative. These compounds have been used in nematic liquid crystal applications. Examples of known pyrimidinyl compounds that have found application in ferroelectric liquid crystal applications can be found in WO 96/30344. These include halogen substituted pyrimidinyldioxane derivatives.
The properties of the LC material used in the manufacture of ferroelectric liquid crystal (FLC) displays exerts a strong influence over the functioning of the display. Apart from the requirement that the FLC exhibit a ferroelectric phase over the entire operating temperature range, there are quite a number of additional requirements that have to be met by the FLC material. These include a low viscosity, large electro-optic effect and chemical and photochemical stability to name but a few. There is, therefore, a need for further liquid crystalline compounds that are able to meet, at least in part, the above mentioned requirements and which can be used in the preparation of ferroelectric liquid crystal phases. The present invention addresses that need.
A first aspect of the invention provides a compound of formula (I)
in which
R1 represents a chiral or non-chiral, branched or straight chain Cι-2υ alkyl or
Cj.20 alkenyl, which may be optionally substituted by one or more halogen atoms and in which one or more non-adjacent -CH2- groups may be optionally replaced by -CH=CH-, -O-, -CO-, -COO-, -OOC-. -O-OC-O- or
-S-;
R2 represents a chiral or non-chiral, branched or straight chain Cι-2n alkoxy, Cj-20 alkenyloxy, Cj-2o alkylcarbonyloxy (alkyl-COO-) or Cι-2υ alkenyl- carbonyloxy (alkenyl-COO-), which may be optionally substituted by one or more halogen atoms and in which one or more non-adjacent -CH2- groups may be optionally replaced by -CH=CH-, -O-. -CO-, -COO-, -OOC-, -O-OC-O- or -S- MG1 represents a group of formula la
-(A-Z ),1-(B-Z )m- la
in which A and B are each independently a 1.4-phenylene or 1 ,4-cyclohexylene group, which may each be optionally substituted by halogen, cyano or nitro or a group of formula R1 and in which one or two non-adjacent -CH- or -CH2- groups may be optionally replaced by nitrogen or oxygen respectively;
Z', Z2, Z3 independently represent a single bond, -COO- or -OOC-, -CH2CH2-, -CH=CH-, -C≡C-, -OCH2- or -CH2O-;
m and n are each independently 0 or 1 ; and
MG represents a 1,4 phenylene group which may be optionally substituted by hhaallooggeenn,, ccyyaannoo oorr nniittrroo oorr aa ggrroouupp ooff ffoorrmmuullaa RR11 and in which one or two non-adjacent -CH- groups is replaced by nitrogen.
The dioxane-pyridine and -pyrimidine derivatives of the present invention may be included in ferroelectric LC mixtures. This allows a skilled person to selectively optimize certain mixture parameters. The parameters that can be optimized include:
1. A wide Sc-phase. This is important not only because the addition of the new components increases the useful phase range, but because it also allows the replacement of existing Sc-components (which are e.g. not stable) without reducing the Sc-range.
2. A large tilt angle. This is important in applications such as DHF-LCDs because it facilitates the preparation of devices having a high brightness. 3. The suppression of the SA-phase. This is important in applications such as APD-LCDs which require an N-Sc* transition without an intervening SΛ-phase. 4. A low birefringence Δn. The dioxane-phenyl-pyrimidine compounds of the present invention have lower birefringence than other common wide temperature range
Sc-components. Lower birefringence is desired for most FLC-LCDs because it enables devices to be prepared having larger cell gaps d, which significantly reduces production difficulties and costs.
It will therefore be appreciated that the use of these compounds either alone or in combination with other liquid crystal components leads to the preparation of LCDs having superior performance characteristics. The group R1 is preferably a branched or straight chain C5-i6 alkyl group.
The group R~ is preferably a branched or straight chain alkoxy or C5-i6 alk- enyloxy group.
The groups R and R may, independently of each other, be chiral. The group MG1 is preferably a 1 ,4-phenylene group, which is optionally substituted by halogen, cyano, nitro, an alkyl or alkoxy group. Z1 , Z2 and Z3 are each preferably a single bond.
The term "alkyl" should be understood to include groups such as methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl and dodecyl. The term "alkenyl" should be understood to include groups such as E or Z alkenyl as well as alkenyl groups with a terminal double bond. Examples of such groups include allyl, 2-butenyl, 2-pentenyl, 2-hexenyl, 2-heptenyl, 2-octenyl, 2-nonenyl, 2-decenyl, 3-but- enyl, 3-pentenyl, 3-hexenyl, 3-heptenyl, 3-octenyl, 3-nonenyl, 3-decenyl, 4-pentenyl, 4-hexenyl, 4-heptenyl, 4-octenyl, 4-nonenyl, 4-decenyl, 5-hexenyl, 6-heptenyl, 7-octenyl, 8-nonenyl, 9-decenyl, 10-undecyl, 1 1-dodecenyl and the like.
The term "alkoxy" should be understood to include groups such as methoxy, ethoxy, n-propoxy, isopropoxy, butoxy, pentyloxy, hexyloxy, heptyloxy, octyloxy, nonyloxy, decyloxy, undecyloxy and dodecyloxy.
The term "alkenyloxy" should be understood to include groups such as 2E-alk- enyloxy, 3Z-alkenyloxy, 4E-alkenyloxy and alkenyloxys with a terminal double bond. The terms "2E-alkenyloxy", "3Z-alkenyloxy" and "4E-alkenyloxy" embrace straight chain alkenyloxy groups with 3 or more, 4 or more and 5 or more carbon atoms respectively in which the double bond is present in the 2. 3 and 4 positions respectively, with E and Z denoting the configuration of the double bond. Such groups include 2E-butenyloxy.
2E-pentenyloxy, 2E-hexenyloxy, 2E-heptenyloxy, 2E-octenyloxy. 2E-nonenyloxy.
2E-decenyloxy, 3-butenyloxy, 3Z-pentenyloxy. 3Z-hexenyloxy, 3Z-heptenyloxy. 3Z-oct- enyloxy, 3Z-nonenyloxy, 3Z-decenyloxy, 4-pentenyloxy, 4E-hexenyloxy. 4E-heptenyloxy.
4E-octenyloxy, 4E-nonenyloxy, 4E-decenyloxy, 5-hexenyloxy, 6-heptenyloxy. 7-oct- enyloxy, 8-nonenyloxy. 9-decenyloxy, 10-undecyloxy, 11-dodecenyloxy and the like.
The term "alkylcarbonyloxy" should be understood to include groups such as methylcarbonyloxy, ethylcarbonyloxy, propylcarbonyloxy, butylcarbonyloxy. pentylcarbonyloxy, hexylcarbonyloxy, octylcarbonyloxy. nonylcarbonyloxy. decylcarbonyloxy, undecylcarbonyloxy and dodecylcarbonyloxy.
The term "alkenylcarbonyloxy" should be understood to include groups such as lE-alkenylcarbonyloxy, 2Z-alkenylcarbonyloxy, 3E-alkenylcarbonyloxy, 4Z-alkenyl- carbonyloxy and alkenylcarbonyloxys with a terminal double bond. The terms "1E- alkenylcarbonyloxy", "2Z-alkenylcarbonyloxy". "3E-alkenylcarbonyloxy" and "4Z-alk- enylcarbonyloxy" embrace straight chain alkenyl groups with 3 or more, 4 or more and 5 or more carbon atoms respectively in which the double bond is present in the 2, 3 and 4 positions respectively, with E and Z denoting the configuration of the double bond. Such groups include allylcarbonyloxy, 2Z-butenylcarbonyloxy, 2Z-pentenylcarbonyloxy. 2Z-hexenylcarbonyloxy, 2Z-heptenylcarbonyloxy, 2Z-octenylcarbonyloxy, 2Z-nonenyl- carbonyloxy, 2Z-decenylcarbonyloxy. 3-butenylcarbonyloxy, 3E-pentenylcarbonyloxy.
3E-hexenylcarbonyloxy, 3E-heptenylcarbonyloxy, 3E-octenylcarbonyloxy, 3E-nonenyl- carbonyloxy, 3E-decenylcarbonyloxy, 4-pentenylcarbonyloxy, 4Z-hexenylcarbonyloxy.
4Z-heptenylcarbonyloxy, 4Z-octenylcarbonyloxy, 4Z-nonenylcarbonyloxy, 4Z-decenyl- carbonyloxy, 5-hexenylcarbonyloxy, 6-heptenylcarbonyloxy, 7-octenylcarbonyloxy.
8-nonenylcarbonyloxy, 9-decenylcarbonyloxy, 10-undecylcarbonyloxy, 1 1-dodecenyl- carbonyloxy and the like.
The term "branched" in relation to the groups R and R" should be understood to mean that any of the foregoing alkyl, alkenyl, alkoxy, alkenyloxy, carboxyalkyl or carb- oxyalkenyl groups may be further substituted with an alkyl or alkenyl group as hereinbefore defined in which one or more hydrogen atoms of the substituted groups may be replaced by a halogen and wherein one or more non-adjacent -CH2- groups may be replaced by -CH=CH-, -O-, -CO-. -COO-, -OOC-, -O-OC-O- or -S-.
The term halogen is understood to include groups such as fluorine, chlorine, bromine and iodine.
In a preferred embodiment of the first aspect of the invention there is provided a compound of formula (II)
in which
R , R" and Z are as defined above for the compound of formula (I);
L to L3 represent, independently, hydrogen, halogen, cyano, nitro or a branched or straight chain Cj-2o alkyl or Cj-2o alkenyl, which may be optionally substituted by one or more halogen atoms and in which one or more non-adjacent -CH2- groups may be optionally replaced by -CH=CH-, -O-, -CO-, -COO-, -OOC-, -O-OC-O- or -S-; and
X represents -CH- or nitrogen.
1 7 1
The particular preferences for R , R and Z are the same as those defined above for the compound of formula (I).
It is preferred that each of L1 to L5 represents hydrogen.
It is preferred that X represents nitrogen
The compounds of the invention may be readily synthesized using known methods such as those indicated in schemes 1 and 2. A second aspect of the invention provides a method for the preparation of the compounds of the invention which comprises the steps of reacting an ether of 4-(5-hydroxy-2-pyrimidyl)benzaldehyde with a 2-alkylpropane-
-1,3-diol to form a dioxane ring.
It should be appreciated that it is not necessary to protect the ether oxygen of the starting material of Scheme 1 with a benzyl group. An alternative preparative method would require the reaction of a long chain alkyl derivative with a diol to form a dioxane ring, thereby removing the necessity to deprotect the hydroxy group by catalytic hydrogenation.
In an alternative embodiment of the second aspect of the invention, there is provided a method for the preparation of the compounds of formula (I) and (II) which comprises reacting a pyrimidine-2-carboxylic acid with a 2-hydroxy derivative of a 1 ,3-dioxane. This is exemplified in Scheme 2.
PTS, toluene
PdC / H,
DEAD, TPP, THF
Scheme 1 in which:
THF tetrahydrofuran
DEAD diethyl azodicarboxylate
TPP triphenylphosphine
PTS para-toluenesulfonic acid
Scheme 2 in which:
EDC is N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride DMAP is 4-dimethylaminopyridine DCM is dichloromethane The starting material used in Scheme 1 may be prepared using the procedure set out in Scheme 3.
O Br^O-
DMF/ POCI3 40°C, 18h
O. = NH
.HCI Et3N / DMF
H2N __^ NFL 2h, 60°C
DMF / Py / MesCI 3h, 55°C
VX ^O-O-OCN
DIBAH / Tol I -40°C...15°C, 4h.
Scheme 3 in which:
DMF is dimethylformamide
POCl3 is phosphorous oxychloride Et3N is triethylamine
Py is pyridine
MesCl is mesyl chloride
DIBAH is diisobutylaluminum hydride; and
Tol is toluene
The branched alkyl-spacer used in the final step of Scheme 1 was synthesized by Fouquet Schlosser coupling (Angew. Chem. 1974, 86(1), 50 - 51) as shown in Scheme 4.
Mg, LiCuCI
BTSS, DCM
Scheme 4 in which: BTSS bis(trimethylsilyl) sulfate DCM dichloromethane
The compounds of the invention may be used alone or as a component of a ferroelectric liquid crystal mixture. A third aspect of the invention therefore provides a ferroelectric liquid crystal mixture comprising a compound of formula (I), the liquid crystal mixture comprising at least two components. The additional component or components of the liquid crystal mixture may comprise one or more compounds of formula (I) or, alternatively, may include other suitable known mesogenic or non-mesogenic compounds. The additional liquid crystal components must be miscible with the compounds of formula (I). Examples of known mesogenic materials suitable for use with the compounds of the present invention are listed below. Further examples of additional components that may be used in the mixtures of the present invention can be found in US 4,898,455. US 4,929,278, US 5.082,589, US 5.238,602, US 5,100.577 and US 5,242,619.
SK IIIc
OHO Illf
Ferroelectric liquid crystal mixtures may be readily prepared by admixing the compounds of formula (I) with one or more additional mesogenic or non-mesogenic components. A fourth aspect of the invention therefore provides a method of preparing a ferroelectric liquid crystal mixture comprising admixing a compound of formula (I) with a further mesogenic or non-mesogenic compound. The one or more additional components may include further compounds of formula (I) or other suitable mesogenic or non-mesogenic components such as those referred to above.
The compounds of the invention may be used in the preparation of ferroelectric liquid crystal devices. As indicated above, such devices have been found to exhibit superior optical and electro-optical properties. A fifth aspect of the invention therefore provides the use of a compound of formula (I) in the preparation of a ferroelectric liquid crystal device. The compounds of formula (I) may be used alone but are most preferably used in the form of a liquid crystal mixture as defined above.
The invention also includes an optic or electo-optic device comprising a compound of formula (I) in addition to an optic or electro-optic device comprising a liquid crystal mixture as defined above. The invention will now be described with reference to the following examples.
Variations on these examples falling within the scope of the invention will be apparent to a person skilled in the art.
Example 1 Preparation of (RS)-5-(8-Methylundecyloxy)-2-[4-(trans-5-octyiπ ,31dioxan-2-yl)- phenyl]pyrimidine
0.44 g (1.20 mmol) 5-hydroxy-2-[4-(trans-5-octyl[1.3]dioxan-2-yl)- phenyl]pyrimidine and 0.25 g (1.32 mmol) (RS)-8-methyl undecan-1 -ol were dissolved in 30 ml tetrahydrofuran (THF). 0.35 g (1.32 mmol) triphenylphosphine and 0.23 g (1.32 mmol) diethyl azodicarboxylate (DEAD) was added and the solution was stirred over night at room temperature. The reaction mixture was then poured into 150 ml water and the product was extracted three times with 50 ml ethyl acetate. The combined organic layers were washed twice with water, dried over magnesium sulfate. filtered and the solvent was evaporated. The crude product was purified by column chromatography on silica gel using cyclohexane/ethyl acetate 7:3 as eluant. Recrystallization from ethanol yields 0.52 g (RS)-5-(8-methylundecyloxy)-2-[4-(trans- -5-octyl-l,3-dioxan-2-yl)phenyl]pyrimidine; melting point (C - Sc) 98.8 °C. phase transition (Sc - N) 135.3 °C, clearing point (N - 1) 145.6 °C.
5-hydroxy-2-[4-(trans-5-octyl-[l ,3]-dioxan-2-yl)phenyl]pyrimidine used as starting material was prepared by the following method:
(a) 10.35 g (55 mmol) 2-hydroxymethyldecan-l-ol and 14.45 g (55 mmol) 2-(4-formylphenyl)-5-benzyloxypyrimidine were suspended in 470 ml toluene. Then 0.5 g p-toluenesulfonic acid was added and the reaction water was removed by azeotropic distillation. After cooling slightly the solution was washed three times with 120 ml warm water. The organic layer was evaporated on a rotary evaporator. Then diethyl ether was added and the solution was allowed to crystallize in a cool place. The crystals were filtered and washed with diethyl ether to give 22.0 g (87 %) 5-(benzyloxy)-2-[4-(trans-5-octyl-l ,3-dioxan-2-yl)phenyl]- pyrimidine as white crystals.
(b) 22.0 g (47.7 g) 5-(benzyloxy)-2-[4-(trans-5-octyl-l ,3-dioxan-2-yl)phenyl]- pyrimidine was suspended in a mixture containing 500 ml dioxane and 500 ml ethanol. After addition of 2.2 ml triethylamine the mixture was hydrogenated at room temperature for 90 minutes using 2.2 g 10 % Pd/C as hydrogenating catalyst. As soon as the hydrogen uptake was complete, the reaction mixture was filtered through dicalcite. Then the solvent was removed. Crystallization of the residue from ethanol gave 9.7 g (66 %) 5-hydroxy-2-[4-(trans-5-octyl[l ,3]dioxan-2-yl)phenyl]pyrimidine as white crystals.
The following compounds can be prepared in a similar fashion:
89.0 125.1 139.8
93.8 134.9 142.6
88.9 136.0 145.6
86.7 134.2 141.0
In which — - represents bonding of neighbouring atoms by a single bond
Example 2
Preparation of Ferroelectric Liquid Crystalline Mixtures
A ferroelectric liquid crystal mixture, SCO-1014, having the composition shown in table
I was prepared. The properties of this mixture were compared with a (15/85) mixture of compound (la) in SCO-1014. The properties of the two mixtures were compared and the results are shown in table II.
Table I: The composition of the test mixture SCO-1014.
12.1 OHO
12.: SHD-
Table la: Compound la.
Table II
N, SA and Sc* are the upper temperature limits of the corresponding LC-phases. A missing phase is denoted by "-". 2Θ is the observed switching angle at 25°C, measured in test cells with 1 OVpp/μm square wave field applied.
The test cells have ITO electrodes, low-tilt, parallel-brushed polyimide orientation layers and a cell gap of 1 Oμm.
The data in table II clearly confirms the excellent influence of dioxane-phenyl-pyrimidine compound (la) on the mixture parameters of the test mixture. In particular:
• The upper limit of the Sc*-phase is increased by 5.6 °C;
• The clearing point is increased by 5.5 °C; and • The switching angle is increased by 13.7°.

Claims

Claims
1. A compound of formula (I)
in which
R1 represents a chiral or non-chiral. branched or straight chain Cι-2o alkyl or
Cj-20 alkenyl, which may be optionally substituted by one or more halogen atoms and in which one or more non-adjacent -CH2- groups may be optionally replaced by -CH=CH-, -O-, -CO-, -COO-, -OOC-, -O-OC-O- or -S-;
R represents a chiral or non-chiral, branched or straight chain Cι-2o alkoxy,
Cι-20 alkenyloxy, Cι-2o alkylcarbonyloxy (alkyl-COO-) or Cj-2o alkenylcarbonyloxy (alkenyl-COO-), which may be optionally substituted by one or more halogen atoms and in which one or more non-adjacent -CH2- groups may be optionally replaced by -CH=CH-, -O-, -CO-, -COO-, -OOC-, -O-OC-O- or -S-
MG represents a group of formula la
-(A-Z2)n-(B-Z3)m- la
in which A and B are each independently a 1 ,4-phenylene or 1 ,4-cyclohexylene group, which may each be optionally substituted by halogen, cyano or nitro or a group of formula R1 and in which one or two non-adjacent -CH- or -CH2- groups may be optionally replaced by nitrogen or oxygen respectively;
Z1, Z2, Z3 independently represent a single bond, -COO- or -OOC-, -CH2CH2-, -CH=CH-, -C≡C-, -OCH2- or -CH2O-; m and n are each independently 0 or 1 ; and
, ?
MG" represents a 1,4 phenylene group which may be optionalh' substituted by halogen, cyano or nitro or a group of formula R1 and in which one or two non-adjacent -CH- groups is replaced by nitrogen.
2. A compound of formula (II)
in which R1 represents a chiral or non-chiral, branched or straight chain Cj-2o alkyl or Cj-20 alkenyl, which may be optionally substituted by one or more halogen atoms and in which one or more non-adjacent -CH2- groups may be optionally replaced by -CH=CH-, -O-, -CO-, -COO-, -OOC-, -O-OC-O- or -S-;
R^ represents a chiral or non-chiral, branched or straight chain Cj.2o alkoxy, Cι-2o alkenyloxy, Cj.2o alkylcarbonyloxy (alkyl-COO-) or Cι-2o alkenylcarbonyloxy (alkenyl-COO-), which may be optionally substituted by one or more halogen atoms and in which one or more non-adjacent -CH2- groups may be optionally replaced by -CH= H-, -O-, -CO-, -COO-, -OOC-, -O-OC-O- or -S-
Zl represent a single bond, -COO- or -OOC-, -CH2CH2-, -CH=CH-, -C≡ -, -OCH2- or -CH2O-;
L to L'"1 represents hydrogen, halogen, cyano, nitro or a branched or straight chain Cι-2o alkyl or Cj-2o alkenyl, which may be optionally substituted by one or more halogen atoms and in which one or more non-adjacent -CH2- groups may be optionally replaced by -CH=CH-. -O-. -CO-. -COO-. -OOC-. -O-OC-O- or -S-; and
X represents -CH- or nitrogen.
3. A compound according to Claim 1 or 2, in which R1 is a branched or straight chain C5-i6 alkyl group.
4. A compound according to any one of claims 1 to 3, in which R1 is an octyl group.
5. A compound according to any one of the preceding claims, in which the group R2 is selected from a branched or straight chain C56 alkoxy or C5-j6 alkenyloxy group.
6. A compound according to Claim 5, in which R2 is selected from the group comprising 2E-octenyloxy, 2E-nonenyloxy, 2E-decenyloxy, 2E-undecenyloxy. 2E-dodecenyloxy. octyloxy, decyloxy, dodecyloxy, 7-methyldecyloxy. 7-methyl- undecyloxy, 8-methyldodecyloxy, 9-methyldodecyloxy and 9-methyltridecyloxy.
7. A compound according to any one of the preceding claims, in which the groups R1 and R are, independently of each other, chiral.
8. A compound according to any one of the preceding claims in which Z1 is a single bond.
9. A compound according to any one of the preceding claims in which L1, L2, L3, L4 and L are hydrogen.
10. A method of preparation of a compound of formula (I) or (II) comprising reacting an ether of a 4-(5-hydroxy-2-pyrimidyl)benzaldehyde with a 2-alkyl-l,3-propanediol.
11. A ferroelectric liquid crystal mixture comprising at least two components, characterized in that one of the components is a compound of formula (I) or (II) as defined in any one of claims 1 to 9.
12. Use of a compound of formula (I) or (II) according to any one of claims 1 to 9, or a liquid crystal mixture according to Claim 11 in the preparation of an optic or an electro-optic device.
13. An optic or electro-optic device comprising a compound of formula (I) or (II) as defined in any one of claims 1 to 9 or a liquid crystal mixture as defined in Claim 11.
EP99954281A 1998-11-23 1999-11-15 Liquid crystal compound Withdrawn EP1137737A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9825628 1998-11-23
GBGB9825628.2A GB9825628D0 (en) 1998-11-23 1998-11-23 Liquid crystal compound
PCT/IB1999/001831 WO2000031211A1 (en) 1998-11-23 1999-11-15 Liquid crystal compound

Publications (1)

Publication Number Publication Date
EP1137737A1 true EP1137737A1 (en) 2001-10-04

Family

ID=10842886

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99954281A Withdrawn EP1137737A1 (en) 1998-11-23 1999-11-15 Liquid crystal compound

Country Status (7)

Country Link
EP (1) EP1137737A1 (en)
JP (1) JP2002530434A (en)
KR (1) KR20010089493A (en)
CN (1) CN1328596A (en)
AU (1) AU1069000A (en)
GB (1) GB9825628D0 (en)
WO (1) WO2000031211A1 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3405914A1 (en) * 1984-02-18 1985-08-22 Merck Patent Gmbh, 6100 Darmstadt LIQUID CRYSTAL LINKS
GB9506309D0 (en) * 1995-03-28 1995-05-17 Secr Defence Pyrimidine compounds
AU5575498A (en) * 1997-01-22 1998-08-18 Chisso Corporation Liquid-crystal compounds, liquid-crystal composition containing the same, and liquid-crystal display element containing the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0031211A1 *

Also Published As

Publication number Publication date
GB9825628D0 (en) 1999-01-13
AU1069000A (en) 2000-06-13
JP2002530434A (en) 2002-09-17
KR20010089493A (en) 2001-10-06
CN1328596A (en) 2001-12-26
WO2000031211A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
EP0697017B1 (en) Novel compounds for use in liquid-crystal compositions
US5849216A (en) Compounds for use in liquid-crystal mixtures
US5384070A (en) Use of optically active tetrahydrofuran-2-carboxylic acid esters as dopants in liquid-crystal mixtures, liquid-crystal mixtures containing same and novel optically active tetrahydrofuran-2-carboxylic acid esters
US5447656A (en) Meta-substituted aromatic compounds having six-membered rings, for use in liquid-crystal mixtures
US5651918A (en) Optically active 1,3-dioxolane derivatives carrying a mesogenic radical in the 4-position, a process for their preparation and their use as doping agents in liquid-crystal mixtures
KR960000076B1 (en) Prepess for preparing chiral esters
US5547605A (en) 2-Aryloxytetrafluoropropionic esters, process for their preparation, and their use in liquid-crystalline mixtures
JPH04234378A (en) Oxazolidinone and use thereof in liquid crystal mixture
JPH0673006A (en) 3-fluoropyridine, its production and its application to liquid crystal compound
JP2001506252A (en) Fluorinated phenanthrene derivatives for liquid crystal mixtures
JPH0717908B2 (en) Method of using optically active 1,3-dioxolane-4-carboxylic acid ester as a dopant in a liquid crystal mixture, liquid crystal mixture containing the ester and novel optically active 1,3-dioxolane-4-carboxylic acid ester
US4906752A (en) Liquid-crystal 5-phenylpyrimidine derivatives having sc or sc* phases and a process for preparing them
US5679792A (en) Derivatives of 3-cyclohexylpropionic acid, and the use thereof in ferroelectric liquid-crystal mixtures
US5707545A (en) Chiral oxiranylmethyl ethers, and their use as dopants in liquid-crystal mixtures
US5200521A (en) Cyclohexylphenylpyrimidines, process for their preparation, and their use in liquid-crystalline mixtures
US5525258A (en) Trifluorophenylene compounds, process for their preparation, and their use in liquid-crystalline mixtures
JPH06228559A (en) Alkyl-substituted hydroquinone derivative for use in ferroelectric liquid crystal mixture
US5562859A (en) 2-fluoropyrazines process for their preparation, and their use in liquid-crystalline mixtures
EP1137737A1 (en) Liquid crystal compound
US5366657A (en) Geminal dimethylalkyl compounds, process for their preparation and their use in liquid-crystalline mixtures
US5366659A (en) Ferroelectric liquid crystals containing pyrimidine and chiral compounds and liquid crystal compositions containing the same
JPH04210940A (en) 3-halo- or 3-cyano-substituted 2-methylalkanedicarboxylic acids and use thereof as dopes in liquid crystal mixture
JPH06211865A (en) Chiral valerolactone derivative
US5336436A (en) Optically active oxirane derivatives, and their use as dopes in liquid-crystal mixtures
US5853612A (en) Compound for use in liquid crystal composition, liquid crystal composition comprising the same, and liquid crystal display device using the same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010519

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

17Q First examination report despatched

Effective date: 20021112

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030820

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1037202

Country of ref document: HK